CNASHighly Regulated (List I)TOLPICALM
NOVAPHARM
Identification
- Active ingredient (INN)
- TOLPERISONE CHLORHYDRATE
- Internal code
- 21 E 060
- Country of Origin
- Algeria
- Pharmaceutical form
- Film-coated Tablet
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/30
CNASDAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Tolperisone is an oral, centrally acting muscle relaxant.
Its precise mechanism is not completely understood, though it blocks sodium and calcium channels.
It possesses a high affinity for nervous system tissue, reaching highest concentrations in brain stem, spinal cord and peripheral nerves.
Based on existing clinical data, Tolperisone is not sedating and does not interact with alcohol.
Indications
Investigated for use/treatment in neurologic disorders, spinal cord injuries, muscle spasm, back pain, and multiple sclerosis.
Mechanism of Action
Sodium channel protein type 11 subunit alpha modulator Humans.
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.